vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $172.2M, roughly 1.2× Acadian Asset Management Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 20.2%, a 37.2% gap on every dollar of revenue.
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
AAMI vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $207.8M |
| Net Profit | $34.7M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 33.3% | 52.2% |
| Net Margin | 20.2% | 57.4% |
| Revenue YoY | 2.6% | — |
| Net Profit YoY | -18.4% | 330.1% |
| EPS (diluted) | $0.97 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | — | ||
| Q3 25 | $144.2M | $207.8M | ||
| Q2 25 | $127.4M | — | ||
| Q1 25 | $119.9M | — | ||
| Q4 24 | $167.8M | — | ||
| Q3 24 | $123.1M | $0 | ||
| Q2 24 | $109.0M | $0 | ||
| Q1 24 | $105.7M | $0 |
| Q4 25 | $34.7M | — | ||
| Q3 25 | $15.1M | $119.2M | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $20.1M | — | ||
| Q4 24 | $42.5M | — | ||
| Q3 24 | $16.9M | $-51.8M | ||
| Q2 24 | $11.0M | $-52.8M | ||
| Q1 24 | $14.6M | $-39.6M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 18.4% | 52.2% | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 26.6% | — | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 18.9% | — | ||
| Q1 24 | 21.7% | — |
| Q4 25 | 20.2% | — | ||
| Q3 25 | 10.5% | 57.4% | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 16.8% | — | ||
| Q4 24 | 25.3% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 13.8% | — |
| Q4 25 | $0.97 | — | ||
| Q3 25 | $0.42 | $1.33 | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.54 | — | ||
| Q4 24 | $1.11 | — | ||
| Q3 24 | $0.45 | $-0.60 | ||
| Q2 24 | $0.29 | $-0.68 | ||
| Q1 24 | $0.37 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | $200.0M | — |
| Stockholders' EquityBook value | — | $1.1B |
| Total Assets | $677.0M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M |
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $275.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $931.7M | ||
| Q1 24 | — | $935.3M |
| Q4 25 | $677.0M | — | ||
| Q3 25 | $751.4M | $1.2B | ||
| Q2 25 | $672.3M | — | ||
| Q1 25 | $677.3M | — | ||
| Q4 24 | $703.2M | — | ||
| Q3 24 | $555.2M | $1.2B | ||
| Q2 24 | $533.1M | $973.7M | ||
| Q1 24 | $544.9M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -0.07× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-23.9M | $142.2M | ||
| Q2 25 | $61.6M | — | ||
| Q1 25 | $-48.8M | — | ||
| Q4 24 | $55.8M | — | ||
| Q3 24 | $69.6M | $-49.2M | ||
| Q2 24 | $45.7M | $-32.9M | ||
| Q1 24 | $-40.4M | $-43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.07× | — | ||
| Q3 25 | -1.58× | 1.19× | ||
| Q2 25 | 6.10× | — | ||
| Q1 25 | -2.43× | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 4.12× | — | ||
| Q2 24 | 4.15× | — | ||
| Q1 24 | -2.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
